Expert Testimony Excluded under Kyocera Where Party Failed to Establish its Expert Possessed the Necessary 'Advanced Training and Experience'

November 1, 2024

Reading Time : 2 min

The Federal Circuit’s decision in Kyocera Senco Industrial Tools Inc. v. International Trade Commission articulated a bright-line test for patent expert admissibility: to testify from the perspective of a “person of ordinary skill in the art” (POSITA), the expert must at least meet the definition of a POSITA for the patents-in-suit. Absent that level of skill, Kyocera holds that the witness’s testimony is not sufficiently reliable or relevant enough to be relied on by a fact-finder.

Applying Kyocera, the court in Wave Neuroscience, Inc. v. Brain Frequency LLC excluded an expert witness’s testimony where the party failed to show that the expert was sufficiently skilled. The plaintiff, Wave Neuroscience, Inc. (“Wave”), sued Brain Frequency LLC (“Brain”) for infringement of a patented technology for treating neurological disorders. At the claim construction stage, the parties disagreed about the level of experience required to be a POSITA in this field. Brain proposed that a POSITA would have, among other things, “advanced training and experience” in either electroencephalogram (EEG) or transcranial magnetic stimulation (TMS) technology. Wave’s proposed POSITA, on the other hand, required training or experience in both EEG and TMS. 

The court determined that the patents at issue were focused on a TMS technique, which uses EEG results, but only as one part of the process. Thus, the court reasoned, EEG training and experience, by itself, could not qualify an expert to testify about TMS. Accordingly, the court agreed with Wave and found that a POSITA would have advanced training or experience in both EEG and TMS.

Under this definition, the court found that Brain failed to demonstrate that its expert had sufficient skill. Although Brain’s expert had a graduate degree in neuroscience and work experience in EEG, the Court determined that his TMS experience was lacking based on his curriculum vitae (CV). The only mention of TMS experience in the expert’s CV was a two-year research project in which the expert was the “primary investigator.” The court disregarded this work because there was no evidence that, as a primary investigator, the expert had a hands-on or technology-facing role where he could have received the required training or experience. Moreover, the defendant’s descriptions of the expert’s experience were too vague for the Court. There were no details about the scope of the expert’s TMS work, the TMS training the expert may have received as part of the study or even a copy of the publication associated with the project. Accordingly, the court would not “take the leap” in assuming the expert had the required experience and found that Brain failed to meet its burden to demonstrate that its expert was qualified to testify under Kyocera and Rule 702. 

Practice Tip: Following Kyocera, differences between an expert’s precise background and the defined level of skill in the art are no longer just fertile areas for cross examination, but grounds for exclusion. Accordingly, practitioners should either ensure that their proffered expert meets the POSITA definition proposed by both sides, or in cases where the level of skill is proposed after experts are selected, ensure that their expert provides detailed evidence beyond his or her CV to demonstrate that every aspect of the proposed definitions are met.

Wave Neuroscience, Inc. v. Brain Frequency LLC, No. SA-23-CV-00626-XR (W.D. Tex. Oct. 4, 2024) (Order Granting Plaintiff’s Motion to Strike).

Share This Insight

Previous Entries

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

IP Newsflash

September 9, 2025

The Federal Circuit has affirmed the PTAB’s determination that a patent challenger did not show the challenged claims were unpatentable for obviousness. The Federal Circuit concluded that substantial evidence, which included expert testimony, showed there was no motivation to combine the references.

...

Read More

IP Newsflash

August 29, 2025

In a recent order addressing four IPR proceedings, the PTAB exercised its inherent authority under 37 C.F.R. § 42.5(a) to sua sponte authorize post-hearing discovery on a potentially dispositive privity issue. The order followed a Director review decision that vacated and remanded earlier IPRs involving the same parties, patent family, and privity issue. 

...

Read More

IP Newsflash

August 29, 2025

The Patent Trial and Appeal Board denied institution of an inter partes review petition in part because it determined that a patent reference was not prior art under the common ownership exception of pre-AIA 35 U.S.C. § 103(c)(1).

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.